Aker Solutions ASA: Annual, Remuneration and Corporate Governance reports for 2024
The reports are attached and also available on https://akersolutions.com/annual-reports and https://akersolutions.com/corporate-governance.
Aker Solutions has also published its annual financial statements in European Single Electronic Format (ESEF), available as an attachment to this release.
CONTACT: Preben Ørbeckinvestor relationspreben.orbeck@akersolutions.com+47 470 10 611
Hallvard Norummedia contacthallvard.norum@akersolutions.com+47 913 80 820
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/aker-solutions-asa/r/aker-solutions-asa--annual--remuneration-and-corporate-governance-reports-for-2024,c4130951
The following files are available for download:
https://mb.cision.com/Main/18353/4130951/3368904.pdf
AKSO - Annual report 2024
https://mb.cision.com/Main/18353/4130951/3368905.zip
5967007LIEEXZXG42836-2024-12-31-en.zip
https://mb.cision.com/Public/18353/4130951/b018820671e2b25e.pdf
Remuneration Report 2024
https://mb.cision.com/Public/18353/4130951/92fd69f5d70e16b6.pdf
Corporate Governance Report 2024
View original content:https://www.prnewswire.co.uk/news-releases/aker-solutions-asa-annual-remuneration-and-corporate-governance-reports-for-2024-302420705.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Implantica publishes Interim Report January - June 2025 (Q2)
VADUZ, Liechtenstein, Aug. 14, 2025 /PRNewswire/ -- Transforming Clinical Excellence of RefluxStop® into Strategic Market Momentum Significant events in the second quarter of 2025 FDA PMA Submission Completed - Submitted third and final module of the U.S. FDA pre-market approval (PMA) application for RefluxStop®, including responses to questions on the second module; Feedback on module 3 expected in the near-term Produced and completed initial testing on new multi-cavity production tool for RefluxStop® to support launch of manufacturing in U.S. and manage ramp-up of U.S. production (pending FDA approval) Additional preparations for U.S. market launch (pending FDA approval) included U.S. payer and reimbursement activities, finalizing new production facility of RefluxStop® in U.S. and launching our RCT (randomized clinical trial), as a heavyweight cornerstone in building global leadership in acid reflux care Positive NICE Guidance in the UK - UK's National Institute for Health and Care Excellence (NICE) issued positive guidance for the use of RefluxStop® in NHS hospitals for patients with ineffective esophageal motility (IOM/IEM), potentially transforming treatment access for millions and influencing global policy Significant events after the end of the period Landmark 5-Year Clinical Study Results - Two peer-reviewed articles were published in Surgical Endoscopy on our pivotal study results; one publication confirmed outstanding long-term safety and effectiveness outcomes, and the second publication highlighted RefluxStop®'s excellent outcomes in food passageway-related sequelae, which is common in standard of care Randomized Clinical Trial (RCT) Launch - First RCT comparing RefluxStop® with Nissen fundoplication; patient recruitment underway accumulating patients across participating hospitals. While this trial preparation led to a 20% year-on-year revenue decline for Q2, the impact is expected to ease once study recruitment stabilizes Spanish Market Expansion - Three new hospitals added, totaling 19 centers offering RefluxStop® in Spain, with a healthcare sytem receptive for new and better patient care, which is a fantastic launch since 2023 First UK National Users Meeting - Convened 21 top anti-reflux experts to discuss real-world results, operating technique and the opportunities arising from NICE's positive recommendation Financial summary second quarter 2025 Net sales decreased 22% to TEUR 433 (554) due to the launch of the randomized clinical trial with surgeons accumulating patients for the trial. Adjusted gross margin amounted to 90% (91%). Operating loss (EBIT) decreased to TEUR 4,525 (5,869). Loss after tax decreased to TEUR 5,448 (6,431). Basic and diluted loss per Class A share amounted to EUR 0.08 (0.09). Cash and short-term investments as at the end of the period of MEUR 56.3. First six months Net sales increased 2% to TEUR 1,178 (1,150). Adjusted gross margin amounted to 94% (91%). Operating loss (EBIT) decreased to TEUR 8,698 (12,956). Loss after tax decreased to TEUR 8,212 (9,903). Basic and diluted loss per Class A share amounted to EUR 0.12 (0.14). Telephone conference Implantica will hold a teleconference on 14 August 2025 at 15:00 (CEST) with Peter Forsell (CEO), Andreas Öhrnberg (CFO), and Nicole Pehrsson (Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast If you wish to participate via webcast, please use the following link: Dial-in Dial-in numbers to the teleconference will be received by registering on the link below. After the registration, you will be provided phone numbers and a conference ID to access the conference. For further information, please contact:Nicole Pehrsson, Chief Corporate Affairs OfficerTelephone (CH): +41 (0)79 335 09 Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm. The company's Certified Adviser is FNCA Sweden AB, info@ This information is information that Implantica AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-08-14 08:00 CEST. About Implantica: Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStop®, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit for further information. This information was brought to you by Cision The following files are available for download: Implantica Q2 2025_ENG Implantica publishes Interim Report Jan - Jun 2025 Q2 View original content:
Yahoo
4 hours ago
- Yahoo
Taiwan's "Star Hotel" and "Taiwan Host B&B" Brands Make Their Debut at 2025 NATAS Holidays Travel Fair in Singapore
TAIPEI, Aug. 14, 2025 /PRNewswire/ -- Taiwan's two official accommodation brands—Taiwan Host B&B and Star Hotel, are making their first appearance at the 2025 NATAS Holidays Travel Fair, holding from August 15–17 at Singapore EXPO Hall 5. Showcasing the warmth of Taiwanese hospitality, the Taiwan Pavilion will offer a range of engaging activities including Taiwan Host B&B ambassador sharing sessions, travel trivia challenges, and social media check-in prize draws. Visitors will also have the exciting opportunity to win a free round-trip flight between Singapore and Taiwan. This news comes from Staynews. Taiwan Host B&B is an official certification program promoting homestays that uphold six core values: friendliness, warmth, cleanliness, hygiene, safety, and quality service. These certified B&Bs offer travelers a high level of service and a comfortable accommodation experience. To date, there are over 1,900 Taiwan Host B&Bs across Taiwan. Among them, 100 "Golden-Award Taiwan Host B&Bs" have been carefully selected and categorized into five themes—Nature & Ecology, Cultural Discovery, Architectural Charm, Family & Pet Travel, and Culinary Delights—designed to meet the diverse travel interests of international visitors. Star Hotels represent another official accommodation brand from Taiwan, selected through a rigorous evaluation process by mystery inspectors who assess over 500 items across both hardware and service. Hotels are ranked from 1 to 3 stars (basic, budget, and comfort) to 4 and 5 stars (deluxe and premium), with a special "5-Star Excellence" level for top-tier properties. There are currently nearly 200 government-certified Star Hotels in Taiwan. These hotels serve as a trusted guide for travelers, providing assurance in both facilities and service quality. A special highlight at the pavilion will be sharing sessions by Golden-Award Taiwan Host B&B ambassadors, who will introduce the unique charms of homestays across Taiwan, covering themes such as nature experiences, cultural immersion, and family/pet-friendly stays. A B&B owner from Kinmen will also host a demonstration of the Mid-Autumn Festival dice game "Bo Bing", along with free tastings of Kinmen's signature souvenirs like peanut brittle and mini pastries, offering Singaporean visitors a nostalgic taste of Nanyang flavor and showcasing the deep connection between Taiwan's local culture and overseas heritage. Visitors who join guided tours of the Taiwan Host B&B and Star Hotel booths and complete a short questionnaire will receive a free bilingual handbook featuring the Golden-Award Taiwan Host B&Bs, along with the chance to take home limited-edition gifts. This appearance at the NATAS Holidays Travel Fair is a milestone in the international outreach of Taiwan's accommodation brands, offering travelers in Singapore a first-hand look at Taiwan's heartfelt hospitality and the character of its accommodation experiences. For more information about Taiwan Host B&Bs and Star Hotels, please visit: (Press release from Staynews : View original content to download multimedia: SOURCE StayNews
Yahoo
8 hours ago
- Yahoo
Seguritech to Attend Mexico's Industry Supply Chain Expo August 13-14
Joining Other Leading Companies to Explore the Entire Industry Value Chain in Mexico MIAMI, Aug. 13, 2025 /PRNewswire/ -- Seguritech, a leader in advanced security technology and hardware integration, today announced its attendance at Mexico's Industry Supply Chain Expo, at Puebla Exhibition Center. Mexico's Industry Supply Chain Expo is the country's flagship annual event dedicated to connecting organizations across the entire industrial value chain and unlocking new business opportunities nationwide. This year's conference is set to welcome over 7,000 companies, representing 16 countries and every state in Mexico, making it one of the most comprehensive gatherings of its kind. With an expected audience of more than 18,000 attendees, the Expo will serve as a dynamic platform for collaboration, innovation, and growth across sectors ranging from manufacturing and logistics to advanced technologies and sustainable solutions. "We're excited to participate in Mexico's 3rd Annual Industry Supply Chain Expo, a premier event that showcases the strength and potential of the country's industrial sector," said Herberto Molina, Managing Director, New Business Development. "As Seguritech drives security innovation for both government and private clients, we value opportunities to collaborate with organizations that share our vision for progress and safety. Our technology solutions — from advanced surveillance to IoT-enabled systems — are essential for building sophisticated, resilient supply chains and supporting the mission-critical infrastructure and processes that keep them running. The Expo is the ideal forum to foster those connections and shape the future together." To learn more about this event, please visit About SeguritechSeguritech is a pioneer in the integration of advanced security technologies, with 30 years of experience transforming and evolving to become a benchmark in the industry. The company delivers comprehensive, innovative solutions that combine surveillance, communications, and data systems to support residential, institutional, and governmental clients. Seguritech is recognized for its commitment to performance, reliability, and the development of smart, integrated safety systems that help create safer, more resilient communities. For more information, please visit and follow us on LinkedIn and X (formerly Twitter). Media Contact:Dan View original content to download multimedia: SOURCE Seguritech Sign in to access your portfolio
